Cargando…
Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure
BACKGROUND: Cotreatment with metformin and Diane-35 is conventionally used in the clinic to ameliorate ovulatory dysfunction and insulin resistance in women with polycystic ovary syndrome (PCOS). We previously showed that this combination treatment could reverse endometrial hyperplasia and endometri...
Autores principales: | Liu, Yanjun, Xu, Ran, Zhou, Yifan, Wang, Yang, Zhang, Feifei, Tong, Xiaoyu, Cui, Peng, Ma, Tong, Sun, Jian, Feng, Yi, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113095/ https://www.ncbi.nlm.nih.gov/pubmed/37082665 http://dx.doi.org/10.21037/atm-21-2441 |
Ejemplares similares
-
Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
por: Zhang, Feifei, et al.
Publicado: (2019) -
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma
por: Liu, Yanjun, et al.
Publicado: (2022) -
Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
por: Li, Xin, et al.
Publicado: (2014) -
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway
por: Zhang, Shun, et al.
Publicado: (2020) -
Diane Lanster /
por: Wolfromm, Jean-Didier
Publicado: (1978)